DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...

Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

As AI technology in healthcare becomes more deeply involved in the complex, high-stakes tasks of diagnosis and treatment ...

The question is whether these AI tools will be another fragmented layer of technology or true assistants to help them spend ...

Healthcare leaders know how to test software. We don't yet have a shared playbook for onboarding agents expected to do a job ...

ADARx Pharmaceuticals upsized its IPO and raised additional cash through a private placement with partner AbbVie. Lead ADARx program onvuzosiran is in Phase 3 testing for the rare disease hereditary ...

CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health ...

Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While ...